Page last updated: 2024-11-05

4-fluoroaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-fluoroaniline: chemical intermediate manufactured by the Halex process; RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-fluoroaniline : A primary arylamine that is the derivative of aniline in which the hydrogen at position 4 has been substituted by fluorine. It is used as an intermediate in the manufacture of pharmaceuticals, herbicides and plant growth regulators. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9731
CHEMBL ID32014
CHEBI ID28546
SCHEMBL ID3199
MeSH IDM0127882

Synonyms (83)

Synonym
p-aminofluorobenzene
brn 0742030
einecs 206-735-5
ccris 5059
4-fluoranilin [czech]
para-fluoroaniline
ai3-52386
hsdb 2691
nsc 579
(4-fluorophenyl)-amine
inchi=1/c6h6fn/c7-5-1-3-6(8)4-2-5/h1-4h,8h
nsc-579
4-fluoronaniline
p-fluorophenylamine
p-fluoroaniline
371-40-4
wln: zr df
aniline, 4-fluoro-
4-fluorobenzenamine
1-amino-4-fluorobenzene
4-fluoroaniline
aniline, p-fluoro-
nsc579
4-fluoranilin
benzenamine, 4-fluoro-
4-fluoroaniline, 99%
CHEMBL32014 ,
4-fluoro-phenylamine
chebi:28546 ,
4-fluorobenzenaminium
4-fluoranylaniline
F0033
bdbm50282614
AKOS000119114
dtxcid602027
NCGC00260374-01
dtxsid9022027 ,
tox21_202828
cas-371-40-4
A823539
STL168895
ec 206-735-5
p-fluoroaniline [un2941] [keep away from food]
unii-60hi1g076z
4-12-00-01104 (beilstein handbook reference)
60hi1g076z ,
4-fluorophenylamine
FT-0618502
4-fluoroaniline [mi]
fluoroaniline, p-
4-fluoroaniline [hsdb]
AM61493
SCHEMBL3199
4-fluoro-aniline
4-fluroaniline
p-fluoro-aniline
4-fluoro aniline
4-fluoro-1-aminobenzene
4-flouroaniline
4-fluorobenzeneamine
4-fluoroanilin
4-floroaniline
(4-fluorophenyl)amine
4- fluoroaniline
4 -fluoroaniline
4flouroaniline
un 2944
PS-9263
mfcd00007829
J-515394
F2190-0427
4-fluoroaniline, technical, >=97.0% (gc)
D78529
4-fluoraniline
Z57127563
picolinafen tp2
4-fluoroanaline
BCP21217
1,4-fluorobenzenamine
Q27103764
p-fluoraniline
EN300-18060
PD055449

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Experiments using rats dosed by the oral route as a model system show that measurement of methaemoglobin content provides a very rapid and simple monitoring method, but is not very sensitive."( 2,4-Difluoroaniline and 4-fluoroaniline exposure: monitoring by methaemoglobin and urine analyses.
Eadsforth, CV; Logan, CJ; Morrison, BJ; Warburton, PA, 1984
)
0.57
"The potential for neurotoxicity after a single oral dose of four halogenated aniline derivatives--4-bromoaniline (4-BA), 4-chloroaniline (4-CA), 4- fluoroaniline (4-FA) and 4-iodoaniline (4-IA)--was given to rats was investigated at or near the lethal dosage level."( Potential of neurotoxicity after a single oral dose of 4-bromo-, 4-chloro-, 4-fluoro- or 4-iodoaniline in rats.
Ishii, H; Okazaki, Y; Sudo, M; Tsuchitani, M; Yamashita, K,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
fluoroanilineA substituted aniline carrying an additional fluoro substituent on the benzene ring.
primary arylamineA primary amine formally derived from ammonia by replacing one hydrogen atom by an aryl group. R-NH2 where R is an aryl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency63.87600.000221.22318,912.5098AID1259381
progesterone receptorHomo sapiens (human)Potency28.53240.000417.946075.1148AID1346784
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency71.67000.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency71.67000.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (33)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
regulation of autophagyHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of epithelial to mesenchymal transitionHistone acetyltransferase KAT8Homo sapiens (human)
neurogenesisHistone acetyltransferase KAT8Homo sapiens (human)
myeloid cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of type I interferon productionHistone acetyltransferase KAT8Homo sapiens (human)
post-embryonic hemopoiesisHistone acetyltransferase KAT8Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
oogenesisHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mRNA processingHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of transcription initiation by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of skeletal muscle satellite cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mitochondrial transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT8Homo sapiens (human)
protein bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
enzyme bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
metal ion bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase KAT8Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT8Homo sapiens (human)
chromatin bindingHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
chromosomeHistone acetyltransferase KAT8Homo sapiens (human)
kinetochoreHistone acetyltransferase KAT8Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
nucleoplasmHistone acetyltransferase KAT8Homo sapiens (human)
mitochondrionHistone acetyltransferase KAT8Homo sapiens (human)
nuclear matrixHistone acetyltransferase KAT8Homo sapiens (human)
NSL complexHistone acetyltransferase KAT8Homo sapiens (human)
MSL complexHistone acetyltransferase KAT8Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
MLL1 complexHistone acetyltransferase KAT8Homo sapiens (human)
chromatinHistone acetyltransferase KAT8Homo sapiens (human)
NuA4 histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID307626Solubility in water
AID307625Partition coefficient, log P of the compound
AID1507709Inhibition of N-terminal His6-tagged KAT8 catalytic domain (125 to 458 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using SGRGKGGKGLGKGGAKRHRK-NH2 as substrate after 5 mins in presence of Ac-CoA by fluorescence assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID167125Eye irritation potential accessed using Draize in vivo rabbit eye irritation test2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's4 (23.53)18.2507
2000's4 (23.53)29.6817
2010's6 (35.29)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.15 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index70.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]